RxDoctor Payments Data

Michelle Cuevas

Family · Rancho Mirage, CANPI 1912233446

Payments from drug & device makers

$2,387in general payments, 2019–2025

Across 91 payments — averaging $26.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$352
  • Bayer$340
  • Amgen$274
  • Actelion Pharmaceuticals US, Inc.$268
  • Abbott$126
  • Esperion Therapeutics, Inc.$125
  • plus $903 from 26 others

What the payments were for

  • Consulting fees$2008%
  • Food & beverage$2,18792%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,387 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.

See all family providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter72$56,261
Stiolto RespimatTiotropium Br/Olodaterol Hcl32$19,933
Breo ElliptaFluticasone/Vilanterol28$13,215
Spiriva RespimatTiotropium Bromide21$10,581
Spiriva HandihalerTiotropium Bromide11$9,546
Advair HfaFluticasone Propion/Salmeterol15$6,043
SymbicortBudesonide/Formoterol Fumarate16$5,035
Albuterol Sulfate HfaAlbuterol Sulfate55$1,386
Fluticasone Propionate28$412
Montelukast Sodium19$187
Methylprednisolone16$115
Prednisone14$46

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$62$69,476100 claims
Boehringer IngelheimStiolto Respimat, Spiriva Respimat$29$30,51453 claims
AstraZenecaSymbicort$83$5,03516 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 10,634 family providers in California.

Other family in Rancho Mirage

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →